Case File
efta-02520598DOJ Data Set 11OtherEFTA02520598
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02520598
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Monday, May 20, 2013 12:20 PM
To:
Fenn, Patrick
Subject:
Re: FW: Early Termination Calculation
could they run the calcuations at a 30 and 35 dollar price=for apo , thanks, also have you given tought to refreshing
the=basis in amh.? new loan,? partnership, guaranteed either payments=or assignment of tra in whole?
On Mon,=May 20, 2013 at 7:46 AM, Fenn, Patrick
Jeffrey,
<=p>
Calculation from Brian Kn=dson at E&Y. Note that this relates only to the unexchanged unit=, and does not
include the existing TRA payments.
<=p>
Regards
<=p>
Hi Patrick,
Attached is the calculation that we put together for Leon. As we=discussed, this only calculates the estimated
early termination payment wi=h respect to the APP units held by Leon - it does not yet calculate the estimated early
termination payment with respect to rema=ning TRA benefits related to the 2007 exchange. I have added an
assumption= tab to the workbook outlining many of the items that we discussed. Thanks=
Brian
Brian Knudson=span style="font-size:10.0pt;font-family:"Arial","sans-se=if""> I Partner I National Tax - Partnership and
Joint Ventures
Ernst & Young LLP
200 South Sixth Street, Suit= 1400, Minneapolis, Minnesota 55402, United States of America
EFTA_R1_01657465
EFTA02520598
Office:
tel:
Mobile:
<tel:
I
mailto
Website: www.ey.com=/span> <http://www.ey.com>
Assistant: Lenora Wold I Pho=e:
<tel
<mailto
Thank you for considering th= environmental impact of printing emails.
Any=U.S. tax advice contained in the body of this e-mail was not intended or w=itten to be used, and cannot be
used, by the recipient for the purpose of =voiding penalties
The information contained in this message may be privileged and confidentia= and protected from disclosure. If
the reader of this message is not the i=tended recipient, or an employee or agent responsible for delivering this =essage
to the intended recipient, you are hereby notified that any dissemination, distribution or copying of=this communication
is strictly prohibited. If you have received this commu=ication in error, please notify us immediately by replying to the
message =nd deleting it from your computer.
Notice required by law: This e-mail may constitute an advertisement or soli=itation under U.S. law, if its primary
purpose is to advertise or promote = commercial product or service. You may choose not to receive advertising =nd
promotional messages from Ernst & Young LLP (except for Ernst & Young Online and the ey.com website which track e-
mail prefe=ences throw h a se arate rocess at this e-mail address by forwarding thi= message to
<mailto
If you do so, the sender of this message will be notified promptly. =ur
principal postal address is 5 Times Square, New York, NY 10036. Thank y=u. Ernst & Young LLP
IRS Circular 230 Notice Requirement: This communication is not given in the=form of a covered opinion, within
the meaning of Circular 230 issued by th= United States Secretary of the Treasury. Thus, we are required to inform =ou
that you cannot rely upon any tax advice contained in this communicatio= for the purpose of avoiding United States
federal tax penalties. In addit=on, any tax advice contained in this communication may not be used to prom=te, market
or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the p=rsonal and confidential use of the
recipient(s) named above. If you have r=ceived this communication in error, please notify us immediately by e-mail= and
delete the original message.
The information contained in this c=mmunication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to
[email protected], =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all
rights reserved
2
EFTA_R1_01657466
EFTA02520599
EFTA_R1_0 1657467
EFTA02520600
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.